Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Getinge AB
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Data from the Extracorporeal Life Support Organization registry shows experienced centers should consider using extracorporeal membrane oxygenation to treat COVID-19-related respiratory failure.
Cardiology device firms relied primarily on in-house lobbyists but also recruited external groups to sway lawmakers to adopt favorable positions on reimbursement, COVID-19, international trade and other issues from January-March 2020, says this Medtech Insight analysis.
The Swedish company has seen a spike in orders of acute care products to treat COVID-19 patients and plans a multi-million investment to expand long-term ECMO production.
- Implantable Devices
- Infection Control-Sterilization
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
- Atrium Medical Corp.
- Datascope Corporation
- Getinge Group
- Getinge GmBH
- InterVascular SAS
- InterVascular Inc.
- Maquet Getinge